Antithrombotic therapy in peripheral arterial occlusive disease

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 666S-682S

  Jackson, Mark R ^a   Clagett, G Patrick ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CARNITINE; CILOSTAZOL; CLOPIDOGREL; DEXTRAN 40; DIPYRIDAMOLE; ECRAPROST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PENTOXIFYLLINE; PICOTAMIDE; PRODRUG; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; STREPTOKINASE; TICLOPIDINE; UNCLASSIFIED DRUG; UROKINASE; WARFARIN;

ANTICOAGULATION; ARTERY EMBOLISM; ARTERY PROSTHESIS; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLITEF IMPLANT; PRIORITY JOURNAL; THROMBECTOMY; VEIN GRAFT;

EID: 0031760828     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.666S     Document Type: Conference Paper

References (2)

1. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982; 211:249-256
2. Jelnes R, Gaardsting O, Hougaard Jensen K, et al. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed) 1986; 293:1137-1140